93 related articles for article (PubMed ID: 17616400)
21. Expression, purification, and antibody binding activity of human papillomavirus 16 L1 protein fused to maltose binding protein.
Cho HJ; Hahm MS; Kim MK; Han IK; Jung WW; Choi HG; Kim JA; Oh YK
Protein Pept Lett; 2007; 14(5):417-24. PubMed ID: 17584165
[TBL] [Abstract][Full Text] [Related]
22. Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1.
Chen XS; Casini G; Harrison SC; Garcea RL
J Mol Biol; 2001 Mar; 307(1):173-82. PubMed ID: 11243812
[TBL] [Abstract][Full Text] [Related]
23. Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types.
Christensen ND; Cladel NM; Reed CA; Budgeon LR; Embers ME; Skulsky DM; McClements WL; Ludmerer SW; Jansen KU
Virology; 2001 Dec; 291(2):324-34. PubMed ID: 11878901
[TBL] [Abstract][Full Text] [Related]
24. An investigation into the use of human papillomavirus type 16 virus-like particles as a delivery vector system for foreign proteins: N- and C-terminal fusion of GFP to the L1 and L2 capsid proteins.
Windram OP; Weber B; Jaffer MA; Rybicki EP; Shepherd DN; Varsani A
Arch Virol; 2008; 153(3):585-9. PubMed ID: 18175039
[TBL] [Abstract][Full Text] [Related]
25. Characterization of an RNA aptamer against HPV-16 L1 virus-like particles.
Leija-Montoya AG; Benítez-Hess ML; Toscano-Garibay JD; Alvarez-Salas LM
Nucleic Acid Ther; 2014 Oct; 24(5):344-55. PubMed ID: 25111024
[TBL] [Abstract][Full Text] [Related]
26. Optimizing the secondary structure of human papillomavirus type 16 L1 mRNA enhances L1 protein expression in Saccharomyces cerevisiae.
Kim HJ; Lee SJ; Kim HJ
J Biotechnol; 2010 Oct; 150(1):31-6. PubMed ID: 20696192
[TBL] [Abstract][Full Text] [Related]
27. Viable adenovirus vaccine prototypes: high-level production of a papillomavirus capsid antigen from the major late transcriptional unit.
Berg M; Difatta J; Hoiczyk E; Schlegel R; Ketner G
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4590-5. PubMed ID: 15767581
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic.
Fernández-San Millán A; Ortigosa SM; Hervás-Stubbs S; Corral-Martínez P; Seguí-Simarro JM; Gaétan J; Coursaget P; Veramendi J
Plant Biotechnol J; 2008 Jun; 6(5):427-41. PubMed ID: 18422886
[TBL] [Abstract][Full Text] [Related]
29. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
[TBL] [Abstract][Full Text] [Related]
30. Expression in Escherichia coli of seven DNA fragments comprising the complete L1 and L2 open reading frames of human papillomavirus type 6b and localization of the 'common antigen' region.
Strike DG; Bonnez W; Rose RC; Reichman RC
J Gen Virol; 1989 Mar; 70 ( Pt 3)():543-55. PubMed ID: 2471790
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus type 16 capsid proteins produced from recombinant Semliki Forest virus assemble into virus-like particles.
Heino P; Dillner J; Schwartz S
Virology; 1995 Dec; 214(2):349-59. PubMed ID: 8553535
[TBL] [Abstract][Full Text] [Related]
32. Oral immunization with different assembly forms of the HPV 16 major capsid protein L1 induces neutralizing antibodies and cytotoxic T-lymphocytes.
Thönes N; Müller M
Virology; 2007 Dec; 369(2):375-88. PubMed ID: 17822733
[TBL] [Abstract][Full Text] [Related]
33. Codon optimization of the human papillomavirus type 58 L1 gene enhances the expression of soluble L1 protein in Saccharomyces cerevisiae.
Kim HJ; Kwag HL; Kim HJ
Biotechnol Lett; 2013 Mar; 35(3):413-21. PubMed ID: 23183918
[TBL] [Abstract][Full Text] [Related]
34. Production and purification of human papillomavirus type 33 L1 virus-like particles from Spodoptera frugiperda 9 cells using two-step column chromatography.
Baek JO; Seo JW; Kim IH; Kim CH
Protein Expr Purif; 2011 Feb; 75(2):211-7. PubMed ID: 20716445
[TBL] [Abstract][Full Text] [Related]
35. Expression of human papillomavirus type 16 L1 protein in Escherichia coli: denaturation, renaturation, and self-assembly of virus-like particles in vitro.
Zhang W; Carmichael J; Ferguson J; Inglis S; Ashrafian H; Stanley M
Virology; 1998 Apr; 243(2):423-31. PubMed ID: 9568041
[TBL] [Abstract][Full Text] [Related]
36. Binding and neutralization efficiencies of monoclonal antibodies, Fab fragments, and scFv specific for L1 epitopes on the capsid of infectious HPV particles.
Culp TD; Spatz CM; Reed CA; Christensen ND
Virology; 2007 May; 361(2):435-46. PubMed ID: 17222883
[TBL] [Abstract][Full Text] [Related]
37. Scalable Production of HPV16 L1 Protein and VLPs from Tobacco Leaves.
Zahin M; Joh J; Khanal S; Husk A; Mason H; Warzecha H; Ghim SJ; Miller DM; Matoba N; Jenson AB
PLoS One; 2016; 11(8):e0160995. PubMed ID: 27518899
[TBL] [Abstract][Full Text] [Related]
38. Optimum conditions for production and purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae.
Park MA; Kim HJ; Kim HJ
Protein Expr Purif; 2008 May; 59(1):175-81. PubMed ID: 18343683
[TBL] [Abstract][Full Text] [Related]
39. Expression of HPV L1 capsid protein in cervical specimens with HPV infection.
Lee H; Lee KJ; Jung CK; Hong JH; Lee YS; Choi YJ; Lee KY; Park G
Diagn Cytopathol; 2008 Dec; 36(12):864-7. PubMed ID: 18855883
[TBL] [Abstract][Full Text] [Related]
40. [Optimized expression of the L1 protein of human papillomavirus in Hansenula polymorpha].
Li W; He X; Guo X; Zhang Z; Zhang B
Sheng Wu Gong Cheng Xue Bao; 2009 Oct; 25(10):1516-23. PubMed ID: 20112696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
